Capital International Sarl trimmed its stake in shares of Nutrien Ltd (NYSE:NTR) by 1.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 81,993 shares of the company’s stock after selling 857 shares during the period. Capital International Sarl’s holdings in Nutrien were worth $3,927,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in NTR. Cidel Asset Management Inc. increased its position in shares of Nutrien by 9.3% during the fourth quarter. Cidel Asset Management Inc. now owns 1,359,026 shares of the company’s stock worth $65,156,000 after acquiring an additional 115,330 shares in the last quarter. Alliancebernstein L.P. grew its position in Nutrien by 1.0% in the fourth quarter. Alliancebernstein L.P. now owns 501,292 shares of the company’s stock valued at $24,017,000 after purchasing an additional 5,082 shares in the last quarter. Janus Henderson Group PLC grew its position in Nutrien by 101.5% in the fourth quarter. Janus Henderson Group PLC now owns 1,336,637 shares of the company’s stock valued at $64,049,000 after purchasing an additional 673,339 shares in the last quarter. Man Group plc grew its position in Nutrien by 164.2% in the fourth quarter. Man Group plc now owns 126,839 shares of the company’s stock valued at $6,077,000 after purchasing an additional 78,838 shares in the last quarter. Finally, Alberta Investment Management Corp grew its position in Nutrien by 217.6% in the fourth quarter. Alberta Investment Management Corp now owns 1,232,818 shares of the company’s stock valued at $59,105,000 after purchasing an additional 844,700 shares in the last quarter. Institutional investors and hedge funds own 64.13% of the company’s stock.
NTR stock traded up $2.36 during trading hours on Thursday, reaching $33.00. The stock had a trading volume of 1,806,284 shares, compared to its average volume of 2,999,170. The stock has a market capitalization of $16.41 billion, a PE ratio of 19.41, a price-to-earnings-growth ratio of 1.56 and a beta of 0.94. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.17 and a quick ratio of 0.62. The stock has a 50-day simple moving average of $37.70 and a 200 day simple moving average of $45.61. Nutrien Ltd has a fifty-two week low of $23.85 and a fifty-two week high of $55.34.
Nutrien (NYSE:NTR) last posted its earnings results on Tuesday, February 18th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.19). The company had revenue of $3.44 billion for the quarter, compared to analyst estimates of $3.36 billion. Nutrien had a return on equity of 5.39% and a net margin of 4.98%. The business’s quarterly revenue was down 8.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.54 EPS. On average, sell-side analysts forecast that Nutrien Ltd will post 2.3 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 5.45%. The ex-dividend date of this dividend is Monday, March 30th. Nutrien’s dividend payout ratio is presently 82.95%.
A number of research analysts recently weighed in on NTR shares. TD Securities decreased their target price on shares of Nutrien from $56.00 to $45.00 and set a “buy” rating for the company in a research report on Tuesday. Bernstein Bank downgraded shares of Nutrien to a “market perform” rating and decreased their target price for the company from $68.00 to $53.00 in a research report on Wednesday, January 15th. Sanford C. Bernstein raised shares of Nutrien from a “market perform” rating to an “outperform” rating and decreased their target price for the company from $53.00 to $52.00 in a research report on Monday, March 2nd. Credit Suisse Group decreased their target price on shares of Nutrien from $50.00 to $49.00 and set a “neutral” rating for the company in a research report on Friday, February 21st. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $55.00 target price on shares of Nutrien in a research report on Thursday, February 20th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $53.73.
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Further Reading: Monthly Dividend Stocks Can Provide Solid Income
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd (NYSE:NTR).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.